Editorial
Nefropatía IgA: ¿qué pacientes están en riesgo de progresar a enfermedad renal terminal y cómo deberían ser tratados?
IgA nephropathy: What patients are at risk of progression to end-stage renal disease and how should they be treated?
Manuel Pragaa,b,
, Fernando Caravacaa, Claudia Yustea, Teresa Caveroa, Eduardo Hernándeza, Enrique Moralesa, Eva Méridaa, Juan Antonio Morenoc, Angel Sevillanoa, Eduardo Gutiérreza
a Servicio de Nefrología, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria, Hospital 12 de Octubre (imas12), Madrid, España
b Departamento de Medicina, Universidad Complutense, Madrid, España
c Renal, Vascular and Diabetes Research Laboratory, Fundación Instituto de Investigaciones Sanitarias-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, España
Leído
63833
Vecesse ha leído el artículo
8460
Total PDF
55373
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 80 | 29 | 109 |
| 2025 10 | 438 | 103 | 541 |
| 2025 9 | 352 | 82 | 434 |
| 2025 8 | 361 | 70 | 431 |
| 2025 7 | 330 | 65 | 395 |
| 2025 6 | 420 | 92 | 512 |
| 2025 5 | 685 | 96 | 781 |
| 2025 4 | 572 | 90 | 662 |
| 2025 3 | 597 | 130 | 727 |
| 2025 2 | 575 | 124 | 699 |
| 2025 1 | 531 | 123 | 654 |
| 2024 12 | 563 | 100 | 663 |
| 2024 11 | 626 | 159 | 785 |
| 2024 10 | 719 | 172 | 891 |
| 2024 9 | 573 | 106 | 679 |
| 2024 8 | 529 | 140 | 669 |
| 2024 7 | 560 | 122 | 682 |
| 2024 6 | 504 | 147 | 651 |
| 2024 5 | 547 | 147 | 694 |
| 2024 4 | 679 | 127 | 806 |
| 2024 3 | 601 | 151 | 752 |
| 2024 2 | 593 | 145 | 738 |
| 2024 1 | 550 | 117 | 667 |
| 2023 12 | 388 | 78 | 466 |
| 2023 11 | 641 | 89 | 730 |
| 2023 10 | 552 | 92 | 644 |
| 2023 9 | 456 | 93 | 549 |
| 2023 8 | 398 | 83 | 481 |
| 2023 7 | 441 | 103 | 544 |
| 2023 6 | 500 | 54 | 554 |
| 2023 5 | 555 | 86 | 641 |
| 2023 4 | 466 | 57 | 523 |
| 2023 3 | 646 | 59 | 705 |
| 2023 2 | 410 | 49 | 459 |
| 2022 1 | 450 | 54 | 504 |
| 2022 12 | 391 | 64 | 455 |
| 2022 11 | 487 | 73 | 560 |
| 2022 10 | 509 | 83 | 592 |
| 2022 9 | 432 | 75 | 507 |
| 2022 8 | 321 | 61 | 382 |
| 2022 7 | 379 | 73 | 452 |
| 2022 6 | 430 | 89 | 519 |
| 2022 5 | 447 | 62 | 509 |
| 2022 4 | 470 | 99 | 569 |
| 2022 3 | 420 | 69 | 489 |
| 2022 2 | 391 | 61 | 452 |
| 2021 1 | 372 | 61 | 433 |
| 2021 12 | 416 | 59 | 475 |
| 2021 11 | 467 | 47 | 514 |
| 2021 10 | 611 | 70 | 681 |
| 2021 9 | 458 | 80 | 538 |
| 2021 8 | 494 | 82 | 576 |
| 2021 7 | 473 | 90 | 563 |
| 2021 6 | 521 | 83 | 604 |
| 2021 5 | 652 | 114 | 766 |
| 2021 4 | 1220 | 165 | 1385 |
| 2021 3 | 738 | 104 | 842 |
| 2021 2 | 584 | 72 | 656 |
| 2020 1 | 582 | 83 | 665 |
| 2020 12 | 675 | 38 | 713 |
| 2020 11 | 665 | 105 | 770 |
| 2020 10 | 535 | 84 | 619 |
| 2020 9 | 554 | 68 | 622 |
| 2020 8 | 473 | 74 | 547 |
| 2020 7 | 485 | 70 | 555 |
| 2020 6 | 636 | 87 | 723 |
| 2020 5 | 719 | 104 | 823 |
| 2020 4 | 941 | 70 | 1011 |
| 2020 3 | 1047 | 100 | 1147 |
| 2020 2 | 993 | 114 | 1107 |
| 2020 1 | 803 | 186 | 989 |
| 2019 12 | 2769 | 211 | 2980 |
| 2019 11 | 1173 | 140 | 1313 |
| 2019 10 | 1803 | 114 | 1917 |
| 2019 9 | 1461 | 131 | 1592 |
| 2019 8 | 1229 | 96 | 1325 |
| 2019 7 | 1109 | 171 | 1280 |
| 2019 6 | 893 | 166 | 1059 |
| 2019 5 | 892 | 141 | 1033 |
| 2019 4 | 840 | 187 | 1027 |
| 2019 3 | 616 | 122 | 738 |
| 2019 2 | 481 | 106 | 587 |
| 2019 1 | 351 | 99 | 450 |
| 2018 12 | 238 | 69 | 307 |
| 2018 11 | 251 | 18 | 269 |
| 2018 10 | 337 | 19 | 356 |
| 2018 9 | 639 | 23 | 662 |
| 2018 8 | 826 | 36 | 862 |
| 2018 7 | 377 | 17 | 394 |
| 2018 6 | 136 | 15 | 151 |
| 2018 5 | 143 | 13 | 156 |
| 2018 4 | 130 | 13 | 143 |
Mostrar todo
